These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 18801857

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.
    Das L, Rastogi A, Jude EB, Prakash M, Dutta P, Bhansali A.
    PLoS One; 2021; 16(11):e0259224. PubMed ID: 34748565
    [Abstract] [Full Text] [Related]

  • 27. Sympathetic neuropathy in diabetes mellitus patients does not elicit Charcot osteoarthropathy.
    Christensen TM, Simonsen L, Holstein PE, Svendsen OL, Bülow J.
    J Diabetes Complications; 2011; 25(5):320-4. PubMed ID: 21813289
    [Abstract] [Full Text] [Related]

  • 28. Pressure pain thresholds at the diabetic Charcot-foot: an exploratory study.
    Chantelau E, Wienemann T, Richter A.
    J Musculoskelet Neuronal Interact; 2012 Jun; 12(2):95-101. PubMed ID: 22647283
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle.
    Sinacore DR, Withrington NC.
    J Orthop Sports Phys Ther; 1999 Dec; 29(12):736-46. PubMed ID: 10612071
    [Abstract] [Full Text] [Related]

  • 31. Doppler spectrum analysis: a potentially useful diagnostic tool for planning the treatment of patients with Charcot arthropathy of the foot?
    Wu T, Chen PY, Chen CH, Wang CL.
    J Bone Joint Surg Br; 2012 Mar; 94(3):344-7. PubMed ID: 22371541
    [Abstract] [Full Text] [Related]

  • 32. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
    Gough A, Abraha H, Li F, Purewal TS, Foster AV, Watkins PJ, Moniz C, Edmonds ME.
    Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Foot bone mass and analysis of calcium metabolism in diabetic patients affected by severe neuropathy.
    Barbaro D, Orsini P, Lapi P, Turco A, Pasquini C.
    Minerva Endocrinol; 2008 Dec; 33(4):283-8. PubMed ID: 18923365
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Teriparatide (recombinant human parathyroid hormone [1-34]) increases foot bone remodeling in diabetic chronic Charcot neuroarthropathy: a randomized double-blind placebo-controlled study.
    Rastogi A, Hajela A, Prakash M, Khandelwal N, Kumar R, Bhattacharya A, Mittal BR, Bhansali A, Armstrong DG.
    J Diabetes; 2019 Sep; 11(9):703-710. PubMed ID: 30632290
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. An analysis of dynamic forces transmitted through the foot in diabetic neuropathy.
    Shaw JE, van Schie CH, Carrington AL, Abbott CA, Boulton AJ.
    Diabetes Care; 1998 Nov; 21(11):1955-9. PubMed ID: 9802750
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.